Transcriptional regulation of CD1D1 by Ets family transcription factors

被引:31
作者
Geng, YB
Laslo, P
Barton, K
Wang, CR
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA
[3] Loyola Univ, Med Ctr, Dept Med, Maywood, IL USA
关键词
D O I
10.4049/jimmunol.175.2.1022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD1 molecules are MHC class I-like glycoproteins specialized in presenting lipid/glycolipid Ags to T cells. The distinct cell-type specific expression of CD1D1 plays an important role in the development and function of NKT cells, a unique subset of immunoregulatory T cells. However, the mechanisms regulating CD1D1 expression are largely unknown. In this study, we have characterized the upstream region of the CD1D1 gene and identified a minimal promoter region within 200 bp from the translational start site of CD1D1 that exhibits cell-type specific promoter activity. Analysis of this region revealed an Ets binding site critical for CD1D1 promoter activity. Gel shift assays and chromatin immunoprecipitation experiments showed that Elf-1 and PU.1 bind to the CD1D1 promoter. Furthermore, we found that gene disruption of Elf-1 resulted in decreased CD1D1 expression on B cells but not other cell types, whereas conditional activation of PU.1 negatively regulated CD1D1 expression in PU.1-deficient myeloid cells. These findings are the first to demonstrate that Ets proteins are involved in the transcriptional regulation of CD1D1 and that they may function uniquely in different cell types.
引用
收藏
页码:1022 / 1029
页数:8
相关论文
共 70 条
[31]   T cell development in mice expressing CD1d directed by a classical MHC class II promoter [J].
Forestier, C ;
Park, SH ;
Wei, DS ;
Benlagha, K ;
Teyton, L ;
Bendelac, A .
JOURNAL OF IMMUNOLOGY, 2003, 171 (08) :4096-4104
[32]   PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1 [J].
Garrett-Sinha, LA ;
Dahl, R ;
Rao, S ;
Barton, KP ;
Simon, MC .
BLOOD, 2001, 97 (09) :2908-2912
[33]   Specificity within the ets family of transcription factors [J].
Graves, BJ ;
Petersen, JM .
ADVANCES IN CANCER RESEARCH, VOL 75, 1998, 75 :1-55
[34]   Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL [J].
Heinemeyer, T ;
Wingender, E ;
Reuter, I ;
Hermjakob, H ;
Kel, AE ;
Kel, OV ;
Ignatieva, EV ;
Ananko, EA ;
Podkolodnaya, OA ;
Kolpakov, FA ;
Podkolodny, NL ;
Kolchanov, NA .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :362-367
[35]   The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice [J].
Hong, S ;
Wilson, MT ;
Serizawa, I ;
Wu, L ;
Singh, N ;
Naidenko, OV ;
Miura, T ;
Haba, T ;
Scherer, DC ;
Wei, J ;
Kronenberg, M ;
Koezuka, Y ;
Van Kaer, L .
NATURE MEDICINE, 2001, 7 (09) :1052-1056
[36]  
HROMAS R, 1993, BLOOD, V82, P2998
[37]   The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells [J].
Kitamura, H ;
Iwakabe, K ;
Yahata, T ;
Nishimura, S ;
Ohta, A ;
Ohmi, Y ;
Sato, M ;
Takeda, K ;
Okumura, K ;
van Kaer, L ;
Kawano, T ;
Taniguchi, M ;
Nishimura, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1121-1127
[38]   THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE [J].
KLEMSZ, MJ ;
MCKERCHER, SR ;
CELADA, A ;
VANBEVEREN, C ;
MAKI, RA .
CELL, 1990, 61 (01) :113-124
[39]   A PUTATIVE 2ND-CELL-DERIVED ONCOGENE OF THE AVIAN LEUKEMIA RETROVIRUS-E26 [J].
LEPRINCE, D ;
GEGONNE, A ;
COLL, J ;
DETAISNE, C ;
SCHNEEBERGER, A ;
LAGROU, C ;
STEHELIN, D .
NATURE, 1983, 306 (5941) :395-397
[40]   Regulation of Ets function by protein-protein interactions [J].
Li, RZ ;
Pei, HP ;
Watson, DK .
ONCOGENE, 2000, 19 (55) :6514-6523